Why Tilray Stock Rallied After its Q3 Results

Here’s why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

| More on:

What happened?

The shares of Tilray (TSX:TLRY)(NASDAQ:TLRY) rose sharply on Wednesday after the company announced the results for Q3 of its fiscal year 2022. During the intraday trading, the TSX-listed TLRY stock jumped by about 16% yesterday before paring some of the gains in the latter half of the session, as the broader market selloff intensified.

So what?

In the third quarter ended in February 2022, Tilray registered 23% YoY (year-over-year) positive growth in its total revenue to around US$151.9 million. However, its latest quarterly revenue figure missed analysts’ estimate of US$156.8 million by a narrow margin.  While its cannabis segment revenue jumped by 32% YoY, the company registered solid 64% growth in its beverage alcohol revenue. In addition, Tilray’s international market cannabis revenue saw a massive increase.

Despite its lower-than-expected revenue, the cannabis giant pleasantly surprised investors by reporting a second consecutive profitable quarter. Tilray’s Q3 adjusted earnings stood at around US$0.09 per share against Street’s expectation of US$0.08-per-share loss. The company cited a reduction in its “assessment of the contingent consideration owed on the SweetWater transaction” as one of the factors that impacted its profits in the February quarter. These factors seemingly helped the company regain investors’ confidence, triggering a rally in TLRY stock price.

Now what?

Currency headwinds stole about US$7 million from Tilray’s distribution segment revenue in the last quarter as the euro continues to weaken against the U.S. dollar. Apart from this temporary negative factor, Tilray’s latest quarterly financial results largely reflected strong positive growth.

After the completion of the Aphria-Tilray merger in May 2021, Tilray has achieved nearly US$76 million in cost synergies. By the end of May 2022, the company expects to reach its goal of achieving US$80 million Synergy — way ahead of schedule. Also, a massive recent rise in its international market revenue reflects optimism for Tilray’s long-term business growth.

Given these positive developments, long-term investors may consider buying TLRY stock right now. Despite yesterday’s sharp rally, Tilray stock continues to underperform the main Canadian market gauge, as it’s trading with only 2% year-to-date gains.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Cannabis Stocks

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »